News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series
AMA backs the PBM Reform Act
“By prioritizing transparency, competitive markets, and enforceable protections for patients this legislation restores integrity to our prescription drug system.
AMA supports PBM reform in annual meeting
In the annual meeting of its House of Delegates, which concluded on June 11, the American Medical Association adopted a resolution opposing PBM spread pricing practices, including supporting state and federal legislation
Our stance on Trump’s drug pricing executive order
The National Community Pharmacists Association released their stance on Trump’s “Most Favorable Pricing” Executive Order, signed on Monday, May 12th.
New FTC chair gets an earful on PBM practices during pharmacy visit
Co-owner of Remington Drug Company in Remington, Va., Al Roberts, welcomed Federal Trade Commission Chair Andrew Ferguson for a pharmacy visit Friday to illustrate the challenges posed by pharmacy benefit managers and emphasize the significant role independent pharmacies play in their communities.
NCPA Joins Class Action Suit Against GoodRx; CVS Caremark Corp.; Express Scripts, Inc.; MedImpact Healthcare Systems, Inc.; and Navitus Health Solutions, LLC
Says the discount card company is colluding with the named PBMs to fix reimbursements
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.